

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptidyl-histidine modification (GO:0018202) | 5.23891369 |
| 2 | regulation of translational termination (GO:0006449) | 4.70097271 |
| 3 | ubiquinone metabolic process (GO:0006743) | 4.65909088 |
| 4 | protein-cofactor linkage (GO:0018065) | 4.65236159 |
| 5 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 4.61206600 |
| 6 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 4.61206600 |
| 7 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 4.61206600 |
| 8 | kynurenine metabolic process (GO:0070189) | 4.49903319 |
| 9 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.48949329 |
| 10 | C4-dicarboxylate transport (GO:0015740) | 4.42298920 |
| 11 | acrosome reaction (GO:0007340) | 4.39353752 |
| 12 | establishment of integrated proviral latency (GO:0075713) | 4.37398284 |
| 13 | adaptation of signaling pathway (GO:0023058) | 4.35908744 |
| 14 | maternal behavior (GO:0042711) | 4.33860669 |
| 15 | regulation of mitotic spindle organization (GO:0060236) | 4.30695203 |
| 16 | regulation of translational fidelity (GO:0006450) | 4.09029298 |
| 17 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.05357561 |
| 18 | neuron remodeling (GO:0016322) | 4.04913087 |
| 19 | positive regulation of macroautophagy (GO:0016239) | 4.04435353 |
| 20 | mitochondrial RNA metabolic process (GO:0000959) | 3.94720570 |
| 21 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.89624368 |
| 22 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.89624368 |
| 23 | ribosome assembly (GO:0042255) | 3.87936150 |
| 24 | parental behavior (GO:0060746) | 3.84539140 |
| 25 | righting reflex (GO:0060013) | 3.82582259 |
| 26 | alanine transport (GO:0032328) | 3.70013712 |
| 27 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 3.65456158 |
| 28 | positive regulation of response to nutrient levels (GO:0032109) | 3.64950709 |
| 29 | positive regulation of response to extracellular stimulus (GO:0032106) | 3.64950709 |
| 30 | rRNA modification (GO:0000154) | 3.59907845 |
| 31 | rRNA methylation (GO:0031167) | 3.57481244 |
| 32 | developmental pigmentation (GO:0048066) | 3.56116952 |
| 33 | glucosamine-containing compound catabolic process (GO:1901072) | 3.55810674 |
| 34 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.52487887 |
| 35 | tryptophan metabolic process (GO:0006568) | 3.51675174 |
| 36 | regulation of hexokinase activity (GO:1903299) | 3.50999283 |
| 37 | regulation of glucokinase activity (GO:0033131) | 3.50999283 |
| 38 | protein complex biogenesis (GO:0070271) | 3.50594009 |
| 39 | establishment of viral latency (GO:0019043) | 3.40255128 |
| 40 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.38883372 |
| 41 | fatty acid elongation (GO:0030497) | 3.38756271 |
| 42 | endosome to pigment granule transport (GO:0043485) | 3.37621897 |
| 43 | endosome to melanosome transport (GO:0035646) | 3.37621897 |
| 44 | embryonic placenta development (GO:0001892) | 3.27991464 |
| 45 | proline biosynthetic process (GO:0006561) | 3.27119008 |
| 46 | respiratory chain complex IV assembly (GO:0008535) | 3.25348413 |
| 47 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.22155952 |
| 48 | lens fiber cell differentiation (GO:0070306) | 3.19990395 |
| 49 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.19529537 |
| 50 | mitochondrial calcium ion transport (GO:0006851) | 3.18788353 |
| 51 | intestinal epithelial cell development (GO:0060576) | 3.17717398 |
| 52 | coenzyme A metabolic process (GO:0015936) | 3.13933966 |
| 53 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.12792302 |
| 54 | regulation of metalloenzyme activity (GO:0048552) | 3.12751748 |
| 55 | regulation of translational elongation (GO:0006448) | 3.10882964 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 3.07187923 |
| 57 | indolalkylamine catabolic process (GO:0046218) | 3.07187923 |
| 58 | tryptophan catabolic process (GO:0006569) | 3.07187923 |
| 59 | isoprenoid biosynthetic process (GO:0008299) | 3.06518133 |
| 60 | sperm-egg recognition (GO:0035036) | 3.03072367 |
| 61 | protein peptidyl-prolyl isomerization (GO:0000413) | 3.01799868 |
| 62 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.99419646 |
| 63 | cytochrome complex assembly (GO:0017004) | 2.99393321 |
| 64 | binding of sperm to zona pellucida (GO:0007339) | 2.97187225 |
| 65 | fructose metabolic process (GO:0006000) | 2.95602253 |
| 66 | ribosomal large subunit biogenesis (GO:0042273) | 2.95111921 |
| 67 | endoderm development (GO:0007492) | 2.95060375 |
| 68 | positive regulation of muscle cell apoptotic process (GO:0010661) | 2.94441517 |
| 69 | regulation of spindle checkpoint (GO:0090231) | 2.92961947 |
| 70 | cellular response to zinc ion (GO:0071294) | 2.92294707 |
| 71 | aggressive behavior (GO:0002118) | 2.91626136 |
| 72 | platelet dense granule organization (GO:0060155) | 2.90797212 |
| 73 | seminiferous tubule development (GO:0072520) | 2.90697474 |
| 74 | regulation of penile erection (GO:0060405) | 2.83048515 |
| 75 | regulation of meiosis I (GO:0060631) | 2.82047375 |
| 76 | mitochondrion transport along microtubule (GO:0047497) | 2.77101069 |
| 77 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.77101069 |
| 78 | regulation of mRNA splicing, via spliceosome (GO:0048024) | 2.75747473 |
| 79 | purine-containing compound salvage (GO:0043101) | 2.74666426 |
| 80 | positive regulation of chromosome segregation (GO:0051984) | 2.73416398 |
| 81 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.73265839 |
| 82 | cellular response to dsRNA (GO:0071359) | 2.69727162 |
| 83 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.68966462 |
| 84 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.68966462 |
| 85 | transcription from mitochondrial promoter (GO:0006390) | 2.67134300 |
| 86 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.66339502 |
| 87 | negative regulation of viral release from host cell (GO:1902187) | 2.65163038 |
| 88 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.64709218 |
| 89 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.64613220 |
| 90 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.63991409 |
| 91 | regulation of histone phosphorylation (GO:0033127) | 2.63206763 |
| 92 | positive regulation of skeletal muscle tissue development (GO:0048643) | 2.62559970 |
| 93 | de novo protein folding (GO:0006458) | 2.62473128 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.62431857 |
| 95 | negative regulation of insulin secretion (GO:0046676) | 2.62404824 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 2.62319466 |
| 97 | regulation of pigment cell differentiation (GO:0050932) | 2.60747761 |
| 98 | pyrimidine nucleoside salvage (GO:0043097) | 2.60708871 |
| 99 | pyrimidine-containing compound salvage (GO:0008655) | 2.60708871 |
| 100 | magnesium ion transport (GO:0015693) | 2.59547016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.91329536 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.29587627 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.91985155 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.39667860 |
| 5 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.24053780 |
| 6 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.17905121 |
| 7 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.99357342 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.87532022 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.86471931 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.86303177 |
| 11 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.71925086 |
| 12 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.71520189 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.71160689 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.59380085 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.51987074 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.44513093 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.40842196 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.36535726 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.31598314 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.16706311 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.11434742 |
| 22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01343826 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.85340228 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.83615910 |
| 25 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.83494233 |
| 26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.80195691 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.79953868 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76267117 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.74449390 |
| 30 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.67863144 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66867675 |
| 32 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66202618 |
| 33 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.63892290 |
| 34 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.62218013 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62056402 |
| 36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61982544 |
| 37 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46561247 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44946893 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44415298 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42475354 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41910600 |
| 42 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.40858529 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40501695 |
| 44 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.39140911 |
| 45 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.39140911 |
| 46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.37853467 |
| 47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37146251 |
| 48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36207136 |
| 49 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.33946812 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.32837006 |
| 51 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.31430215 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31258852 |
| 53 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.29574578 |
| 54 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.29129220 |
| 55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26204819 |
| 56 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25530109 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24264462 |
| 58 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18856828 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17517496 |
| 60 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.15670446 |
| 61 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.14920248 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14357082 |
| 63 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11024141 |
| 64 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10277139 |
| 65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09725738 |
| 66 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08550049 |
| 67 | NCOR_22424771_ChIP-Seq_293T_Human | 1.07194674 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98592321 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 0.98345047 |
| 70 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97822001 |
| 71 | EWS_26573619_Chip-Seq_HEK293_Human | 0.96888856 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95650944 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94171729 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93997911 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93689139 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93085832 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92798415 |
| 78 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.92249424 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88747042 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86468379 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85394445 |
| 82 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.83068796 |
| 83 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.82735141 |
| 84 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.81678841 |
| 85 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.80047806 |
| 86 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.79336275 |
| 87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79083721 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.78969053 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78450249 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78108549 |
| 91 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.77734737 |
| 92 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.77016423 |
| 93 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75933030 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.75702324 |
| 95 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.74674332 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73270836 |
| 97 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72149996 |
| 98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.71470721 |
| 99 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.71250245 |
| 100 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.71049454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 9.18336152 |
| 2 | MP0005409_darkened_coat_color | 5.67735661 |
| 3 | MP0001188_hyperpigmentation | 4.10978142 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 4.06388967 |
| 5 | MP0005174_abnormal_tail_pigmentation | 3.46928862 |
| 6 | MP0003303_peritoneal_inflammation | 3.35548183 |
| 7 | MP0002102_abnormal_ear_morphology | 3.25604883 |
| 8 | MP0000015_abnormal_ear_pigmentation | 3.23571819 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.09768963 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.97046363 |
| 11 | MP0001542_abnormal_bone_strength | 2.50797398 |
| 12 | MP0005187_abnormal_penis_morphology | 2.46515885 |
| 13 | MP0008057_abnormal_DNA_replication | 2.34463028 |
| 14 | MP0005410_abnormal_fertilization | 2.22870177 |
| 15 | MP0003646_muscle_fatigue | 2.20070625 |
| 16 | MP0000647_abnormal_sebaceous_gland | 2.06842249 |
| 17 | MP0009697_abnormal_copulation | 2.04332833 |
| 18 | MP0005464_abnormal_platelet_physiology | 1.99780346 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 1.96400708 |
| 20 | MP0003283_abnormal_digestive_organ | 1.82787445 |
| 21 | MP0009840_abnormal_foam_cell | 1.73783402 |
| 22 | MP0002095_abnormal_skin_pigmentation | 1.68204854 |
| 23 | MP0002638_abnormal_pupillary_reflex | 1.62216508 |
| 24 | MP0003252_abnormal_bile_duct | 1.57078616 |
| 25 | MP0009785_altered_susceptibility_to | 1.51392807 |
| 26 | MP0004510_myositis | 1.49679480 |
| 27 | MP0002693_abnormal_pancreas_physiology | 1.42657071 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.41784157 |
| 29 | MP0008058_abnormal_DNA_repair | 1.41436005 |
| 30 | MP0000383_abnormal_hair_follicle | 1.37422108 |
| 31 | MP0001968_abnormal_touch/_nociception | 1.27697200 |
| 32 | MP0001986_abnormal_taste_sensitivity | 1.21791442 |
| 33 | MP0001243_abnormal_dermal_layer | 1.18774107 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.17387698 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.17128984 |
| 36 | MP0003111_abnormal_nucleus_morphology | 1.16266369 |
| 37 | MP0002269_muscular_atrophy | 1.15393272 |
| 38 | MP0000604_amyloidosis | 1.12430641 |
| 39 | MP0003786_premature_aging | 1.10629819 |
| 40 | MP0005171_absent_coat_pigmentation | 1.09947377 |
| 41 | MP0002928_abnormal_bile_duct | 1.08009650 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.05334979 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.03439481 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 0.97846206 |
| 45 | MP0002282_abnormal_trachea_morphology | 0.96732760 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 0.95865541 |
| 47 | MP0002736_abnormal_nociception_after | 0.95434174 |
| 48 | MP0000613_abnormal_salivary_gland | 0.93845431 |
| 49 | MP0003075_altered_response_to | 0.92968780 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 0.92088004 |
| 51 | MP0005165_increased_susceptibility_to | 0.85349866 |
| 52 | MP0002177_abnormal_outer_ear | 0.84017282 |
| 53 | MP0005266_abnormal_metabolism | 0.83804064 |
| 54 | MP0003195_calcinosis | 0.83168483 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 0.80611890 |
| 56 | MP0005166_decreased_susceptibility_to | 0.78426873 |
| 57 | MP0003718_maternal_effect | 0.77484997 |
| 58 | MP0001661_extended_life_span | 0.73902156 |
| 59 | MP0003448_altered_tumor_morphology | 0.73223451 |
| 60 | MP0001845_abnormal_inflammatory_respons | 0.71915491 |
| 61 | MP0002332_abnormal_exercise_endurance | 0.68706903 |
| 62 | MP0002127_abnormal_cardiovascular_syste | 0.66843808 |
| 63 | MP0003186_abnormal_redox_activity | 0.66092211 |
| 64 | MP0000343_altered_response_to | 0.64758213 |
| 65 | MP0005595_abnormal_vascular_smooth | 0.64230952 |
| 66 | MP0002106_abnormal_muscle_physiology | 0.63688093 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 0.62951790 |
| 68 | MP0008260_abnormal_autophagy | 0.62581977 |
| 69 | MP0000750_abnormal_muscle_regeneration | 0.60863091 |
| 70 | MP0001905_abnormal_dopamine_level | 0.60319712 |
| 71 | MP0002733_abnormal_thermal_nociception | 0.58723357 |
| 72 | MP0002163_abnormal_gland_morphology | 0.58229596 |
| 73 | MP0002405_respiratory_system_inflammati | 0.57699459 |
| 74 | MP0008872_abnormal_physiological_respon | 0.56457572 |
| 75 | MP0008873_increased_physiological_sensi | 0.56228925 |
| 76 | MP0008469_abnormal_protein_level | 0.56226760 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.55637197 |
| 78 | MP0005623_abnormal_meninges_morphology | 0.55588986 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.55123079 |
| 80 | MP0005395_other_phenotype | 0.52827917 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.52661296 |
| 82 | MP0003279_aneurysm | 0.52620218 |
| 83 | MP0001944_abnormal_pancreas_morphology | 0.52557389 |
| 84 | MP0000516_abnormal_urinary_system | 0.51639551 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 0.51639551 |
| 86 | MP0001730_embryonic_growth_arrest | 0.50154311 |
| 87 | MP0004957_abnormal_blastocyst_morpholog | 0.49669626 |
| 88 | MP0003795_abnormal_bone_structure | 0.49451671 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.49065134 |
| 90 | MP0005671_abnormal_response_to | 0.48904159 |
| 91 | MP0000467_abnormal_esophagus_morphology | 0.48793654 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.48454330 |
| 93 | MP0002938_white_spotting | 0.48198211 |
| 94 | MP0005330_cardiomyopathy | 0.47726271 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.47452284 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.45973162 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.44779651 |
| 98 | MP0010771_integument_phenotype | 0.44485723 |
| 99 | MP0003941_abnormal_skin_development | 0.43569237 |
| 100 | MP0005164_abnormal_response_to | 0.43013187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.05693160 |
| 2 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.05693160 |
| 3 | Fibular aplasia (HP:0002990) | 3.86989249 |
| 4 | Ependymoma (HP:0002888) | 3.72552094 |
| 5 | Choroideremia (HP:0001139) | 3.70694984 |
| 6 | Hypoglycemic seizures (HP:0002173) | 3.62470351 |
| 7 | Facial hemangioma (HP:0000329) | 3.57922796 |
| 8 | Buphthalmos (HP:0000557) | 3.52229785 |
| 9 | Increased intramyocellular lipid droplets (HP:0012240) | 3.47661609 |
| 10 | Methylmalonic acidemia (HP:0002912) | 3.43826465 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.39919402 |
| 12 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.34713783 |
| 13 | Hypothermia (HP:0002045) | 3.25796807 |
| 14 | Conjunctival telangiectasia (HP:0000524) | 3.24856611 |
| 15 | Congenital glaucoma (HP:0001087) | 3.12544082 |
| 16 | Reduced antithrombin III activity (HP:0001976) | 3.07091236 |
| 17 | Abnormality of the costochondral junction (HP:0000919) | 3.07018632 |
| 18 | Medulloblastoma (HP:0002885) | 3.05312945 |
| 19 | Limb-girdle muscle atrophy (HP:0003797) | 2.98542040 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 2.97555332 |
| 21 | Large for gestational age (HP:0001520) | 2.95077901 |
| 22 | Abnormality of the astrocytes (HP:0100707) | 2.92598907 |
| 23 | Astrocytoma (HP:0009592) | 2.92598907 |
| 24 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.90951077 |
| 25 | Symptomatic seizures (HP:0011145) | 2.90545611 |
| 26 | Hepatic necrosis (HP:0002605) | 2.89835763 |
| 27 | Cortical dysplasia (HP:0002539) | 2.87219410 |
| 28 | Distal lower limb amyotrophy (HP:0008944) | 2.85773223 |
| 29 | Type I transferrin isoform profile (HP:0003642) | 2.85089773 |
| 30 | Late onset (HP:0003584) | 2.84518229 |
| 31 | Type I diabetes mellitus (HP:0100651) | 2.80497820 |
| 32 | Aplasia cutis congenita (HP:0001057) | 2.77092925 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.75501810 |
| 34 | Metaphyseal dysplasia (HP:0100255) | 2.72825644 |
| 35 | Increased muscle lipid content (HP:0009058) | 2.72565342 |
| 36 | Lower limb hyperreflexia (HP:0002395) | 2.70042964 |
| 37 | Beaking of vertebral bodies (HP:0004568) | 2.69648277 |
| 38 | Ketoacidosis (HP:0001993) | 2.68374405 |
| 39 | Rhabdomyosarcoma (HP:0002859) | 2.64820356 |
| 40 | Abnormal pupillary function (HP:0007686) | 2.58626158 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.57347751 |
| 42 | Autoamputation (HP:0001218) | 2.53169078 |
| 43 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.52350503 |
| 44 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.50440160 |
| 45 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.50440160 |
| 46 | Exocrine pancreatic insufficiency (HP:0001738) | 2.49953046 |
| 47 | Increased CSF lactate (HP:0002490) | 2.48118672 |
| 48 | Lower limb amyotrophy (HP:0007210) | 2.41051595 |
| 49 | Brushfield spots (HP:0001088) | 2.38224973 |
| 50 | Mitochondrial inheritance (HP:0001427) | 2.37723299 |
| 51 | Spastic paraparesis (HP:0002313) | 2.36632954 |
| 52 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.35564808 |
| 53 | Cholecystitis (HP:0001082) | 2.33853247 |
| 54 | Abnormal gallbladder physiology (HP:0012438) | 2.33853247 |
| 55 | Neoplasm of striated muscle (HP:0009728) | 2.33584493 |
| 56 | Hyperglycemia (HP:0003074) | 2.29464348 |
| 57 | 3-Methylglutaconic aciduria (HP:0003535) | 2.28619016 |
| 58 | Increased hepatocellular lipid droplets (HP:0006565) | 2.26903722 |
| 59 | Onycholysis (HP:0001806) | 2.25561010 |
| 60 | Methylmalonic aciduria (HP:0012120) | 2.21976638 |
| 61 | Zonular cataract (HP:0010920) | 2.16326648 |
| 62 | Glioma (HP:0009733) | 2.14414607 |
| 63 | Chronic diarrhea (HP:0002028) | 2.13318476 |
| 64 | Acute necrotizing encephalopathy (HP:0006965) | 2.10532967 |
| 65 | Heterochromia iridis (HP:0001100) | 2.07721045 |
| 66 | Insulin resistance (HP:0000855) | 2.07480062 |
| 67 | Corneal dystrophy (HP:0001131) | 2.05937915 |
| 68 | Upper limb muscle weakness (HP:0003484) | 2.01989953 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 1.99440934 |
| 70 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.99440934 |
| 71 | Respiratory failure (HP:0002878) | 1.98321074 |
| 72 | Tongue fasciculations (HP:0001308) | 1.96920794 |
| 73 | Chronic bronchitis (HP:0004469) | 1.96055337 |
| 74 | Steatorrhea (HP:0002570) | 1.95239893 |
| 75 | Lipid accumulation in hepatocytes (HP:0006561) | 1.93839331 |
| 76 | Progressive macrocephaly (HP:0004481) | 1.93831797 |
| 77 | Dyskinesia (HP:0100660) | 1.93551729 |
| 78 | Abnormal trabecular bone morphology (HP:0100671) | 1.92579435 |
| 79 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.91876591 |
| 80 | Rough bone trabeculation (HP:0100670) | 1.91224551 |
| 81 | Renal cortical cysts (HP:0000803) | 1.91153319 |
| 82 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.90784688 |
| 83 | Hypoplasia of the fovea (HP:0007750) | 1.90784688 |
| 84 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.89097824 |
| 85 | Hamartoma of the eye (HP:0010568) | 1.87475409 |
| 86 | Porencephaly (HP:0002132) | 1.87380141 |
| 87 | Palpitations (HP:0001962) | 1.87307105 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 1.86347534 |
| 89 | Abnormal glycosylation (HP:0012345) | 1.86347534 |
| 90 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86347534 |
| 91 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86347534 |
| 92 | Adrenal hypoplasia (HP:0000835) | 1.83999441 |
| 93 | Termporal pattern (HP:0011008) | 1.83842057 |
| 94 | Insidious onset (HP:0003587) | 1.83842057 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82361385 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82361385 |
| 97 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82361385 |
| 98 | Neoplasm of the adrenal cortex (HP:0100641) | 1.82319252 |
| 99 | Humeroradial synostosis (HP:0003041) | 1.82229138 |
| 100 | Synostosis involving the elbow (HP:0003938) | 1.82229138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 5.93152547 |
| 2 | BUB1 | 4.55126440 |
| 3 | SCYL2 | 3.67066286 |
| 4 | IRAK3 | 3.18457307 |
| 5 | CDC7 | 3.00241119 |
| 6 | MST4 | 2.86108101 |
| 7 | LIMK1 | 2.77518923 |
| 8 | TESK1 | 2.54168064 |
| 9 | EPHA2 | 2.44719123 |
| 10 | NEK1 | 2.40611978 |
| 11 | MAP4K2 | 2.26047613 |
| 12 | EIF2AK1 | 2.23358678 |
| 13 | TRIM28 | 2.20841900 |
| 14 | MAPKAPK3 | 2.06085466 |
| 15 | STK16 | 1.91641497 |
| 16 | TESK2 | 1.89709662 |
| 17 | STK24 | 1.81259098 |
| 18 | NME2 | 1.73718343 |
| 19 | PASK | 1.55677973 |
| 20 | ERBB4 | 1.43290028 |
| 21 | STK38L | 1.39579056 |
| 22 | CSNK1G3 | 1.28419560 |
| 23 | MAP2K6 | 1.27397355 |
| 24 | ERBB3 | 1.24841019 |
| 25 | SRPK1 | 1.23443189 |
| 26 | JAK3 | 1.21814278 |
| 27 | MINK1 | 1.21757632 |
| 28 | CSNK1G1 | 1.21650475 |
| 29 | MST1R | 1.16465230 |
| 30 | FRK | 1.15526842 |
| 31 | DAPK1 | 1.08042944 |
| 32 | TRPM7 | 1.06319841 |
| 33 | PAK4 | 1.03877161 |
| 34 | MAP3K9 | 1.03793211 |
| 35 | CSNK1A1L | 1.00342865 |
| 36 | STK3 | 0.98615255 |
| 37 | TSSK6 | 0.97230965 |
| 38 | GRK1 | 0.96300407 |
| 39 | RPS6KA4 | 0.95394787 |
| 40 | ADRBK2 | 0.92241044 |
| 41 | LMTK2 | 0.91475124 |
| 42 | PIM2 | 0.88531974 |
| 43 | PRKD3 | 0.87221034 |
| 44 | CDK6 | 0.84526007 |
| 45 | ATR | 0.79207702 |
| 46 | MAP3K8 | 0.79102266 |
| 47 | STK10 | 0.77809914 |
| 48 | MAP3K12 | 0.74723711 |
| 49 | CSNK1G2 | 0.74693023 |
| 50 | PLK2 | 0.70163985 |
| 51 | PAK6 | 0.69832115 |
| 52 | PHKG2 | 0.69084934 |
| 53 | PHKG1 | 0.69084934 |
| 54 | GSK3A | 0.68571769 |
| 55 | PLK3 | 0.65892681 |
| 56 | TTK | 0.62808853 |
| 57 | DAPK2 | 0.59894443 |
| 58 | MAP3K3 | 0.58494835 |
| 59 | VRK2 | 0.58492366 |
| 60 | PRKD2 | 0.55556991 |
| 61 | EIF2AK3 | 0.55251085 |
| 62 | MAP2K7 | 0.54529686 |
| 63 | KDR | 0.54448951 |
| 64 | ADRBK1 | 0.50947993 |
| 65 | STK39 | 0.50581119 |
| 66 | IKBKB | 0.47436244 |
| 67 | PLK4 | 0.47019526 |
| 68 | IGF1R | 0.45037972 |
| 69 | CAMK2G | 0.42796971 |
| 70 | WNK3 | 0.41851423 |
| 71 | ROCK2 | 0.41363356 |
| 72 | WEE1 | 0.41020349 |
| 73 | IRAK2 | 0.40953565 |
| 74 | WNK4 | 0.39089490 |
| 75 | ROCK1 | 0.38869259 |
| 76 | CLK1 | 0.37716110 |
| 77 | ABL2 | 0.37580049 |
| 78 | PTK2B | 0.37109678 |
| 79 | NTRK3 | 0.36718190 |
| 80 | INSRR | 0.35711624 |
| 81 | EGFR | 0.35696574 |
| 82 | PRKCI | 0.35335818 |
| 83 | ALK | 0.35247693 |
| 84 | CAMK2A | 0.35012695 |
| 85 | ABL1 | 0.34815170 |
| 86 | BCKDK | 0.34625117 |
| 87 | CSNK1A1 | 0.34398827 |
| 88 | MYLK | 0.33049228 |
| 89 | FLT3 | 0.32821737 |
| 90 | AURKA | 0.31873825 |
| 91 | FGFR3 | 0.31640471 |
| 92 | LRRK2 | 0.31368765 |
| 93 | PAK1 | 0.27779318 |
| 94 | MKNK1 | 0.26797235 |
| 95 | TAOK2 | 0.25812205 |
| 96 | MAPK11 | 0.25204358 |
| 97 | DAPK3 | 0.25121946 |
| 98 | LATS1 | 0.24965586 |
| 99 | GRK7 | 0.24749936 |
| 100 | NUAK1 | 0.24216340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.98452618 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.80132136 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.59577267 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.32504874 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.84819076 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.83462514 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.60682998 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.40902328 |
| 9 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.35175163 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.27788262 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.21331158 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.20325208 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.07003020 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.94399995 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.93889153 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87671280 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.82387214 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79112656 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73283635 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.65127679 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47795673 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.47362917 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.46751471 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.41444859 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.38728165 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38038573 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35237622 |
| 28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.29523022 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23576630 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23182512 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17829132 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.15876703 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13859994 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08216743 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07382282 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.05102842 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03326630 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98126699 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 0.97433752 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97416380 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92086613 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89817259 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 0.89259329 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.84815612 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83743153 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 0.83405065 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82979505 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82698027 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81367058 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79956520 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75385054 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73947756 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73915320 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73312431 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71562004 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.70742086 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70511681 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 0.64701260 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64549646 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.63012981 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.62163364 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62031042 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61833088 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61276287 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61136628 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.58608364 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55582026 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.54918828 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.52617567 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52390385 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52226887 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51713695 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50343889 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50295813 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49530263 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47205629 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.46950624 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46859397 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44447237 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43762584 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43537383 |
| 82 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41688678 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41272053 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39460837 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36466677 |
| 86 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36320577 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34413169 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33965174 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29231942 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.28611243 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28167645 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26253353 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.25158655 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.24419769 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24298484 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.22639493 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.22433582 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22324342 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.20718529 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20641272 |

